UBS Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$215K Buy
300,110
+175,839
+141% +$126K ﹤0.01% 5434
2025
Q1
$183K Sell
124,271
-2,054,990
-94% -$3.02M ﹤0.01% 5369
2024
Q4
$9.65M Buy
2,179,261
+1,232,377
+130% +$5.46M ﹤0.01% 2374
2024
Q3
$3.9M Sell
946,884
-892,915
-49% -$3.68M ﹤0.01% 2491
2024
Q2
$12M Sell
1,839,799
-1,187,916
-39% -$7.75M ﹤0.01% 1509
2024
Q1
$26.4M Buy
3,027,715
+2,582,407
+580% +$22.5M 0.01% 1050
2023
Q4
$5.09M Sell
445,308
-449,766
-50% -$5.15M ﹤0.01% 1999
2023
Q3
$8.62M Buy
895,074
+207,756
+30% +$2M ﹤0.01% 1486
2023
Q2
$7.31M Sell
687,318
-99,766
-13% -$1.06M ﹤0.01% 1619
2023
Q1
$8.28M Sell
787,084
-33,197
-4% -$349K ﹤0.01% 1476
2022
Q4
$10.2M Buy
820,281
+712,596
+662% +$8.83M ﹤0.01% 1380
2022
Q3
$1.12M Sell
107,685
-9,468
-8% -$98K ﹤0.01% 2775
2022
Q2
$1.35M Sell
117,153
-313,078
-73% -$3.61M ﹤0.01% 2664
2022
Q1
$5.41M Sell
430,231
-28,067
-6% -$353K ﹤0.01% 1865
2021
Q4
$5.35M Sell
458,298
-164,359
-26% -$1.92M ﹤0.01% 2034
2021
Q3
$8.13M Buy
622,657
+231,156
+59% +$3.02M ﹤0.01% 1642
2021
Q2
$5.04M Buy
391,501
+383,281
+4,663% +$4.93M ﹤0.01% 2005
2021
Q1
$92K Buy
8,220
+2,069
+34% +$23.2K ﹤0.01% 5041
2020
Q4
$70K Sell
6,151
-59,640
-91% -$679K ﹤0.01% 4932
2020
Q3
$592K Sell
65,791
-64,734
-50% -$582K ﹤0.01% 3293
2020
Q2
$1.35M Sell
130,525
-322,425
-71% -$3.33M ﹤0.01% 2589
2020
Q1
$4.57M Sell
452,950
-305,929
-40% -$3.09M ﹤0.01% 1565
2019
Q4
$10.1M Sell
758,879
-176,735
-19% -$2.35M ﹤0.01% 1485
2019
Q3
$8.03M Buy
935,614
+513,070
+121% +$4.4M ﹤0.01% 1502
2019
Q2
$4.62M Sell
422,544
-57,904
-12% -$634K ﹤0.01% 1872
2019
Q1
$4.56M Sell
480,448
-548,544
-53% -$5.2M ﹤0.01% 1836
2018
Q4
$8.93M Buy
1,028,992
+168,926
+20% +$1.47M ﹤0.01% 1300
2018
Q3
$13.3M Buy
860,066
+597,343
+227% +$9.24M 0.01% 1209
2018
Q2
$4.21M Buy
262,723
+77,704
+42% +$1.24M ﹤0.01% 1992
2018
Q1
$2.39M Buy
185,019
+159,568
+627% +$2.06M ﹤0.01% 2427
2017
Q4
$319K Sell
25,451
-35,613
-58% -$446K ﹤0.01% 3733
2017
Q3
$807K Buy
61,064
+46,134
+309% +$610K ﹤0.01% 3136
2017
Q2
$236K Buy
14,930
+14,389
+2,660% +$227K ﹤0.01% 3810
2017
Q1
$8K Sell
541
-64,142
-99% -$948K ﹤0.01% 5819
2016
Q4
$828K Buy
64,683
+64,517
+38,866% +$826K ﹤0.01% 2956
2016
Q3
$2K Sell
166
-20,558
-99% -$248K ﹤0.01% 6460
2016
Q2
$227K Buy
20,724
+10,269
+98% +$112K ﹤0.01% 3680
2016
Q1
$95K Sell
10,455
-125,489
-92% -$1.14M ﹤0.01% 4272
2015
Q4
$1.32M Buy
135,944
+132,859
+4,307% +$1.29M ﹤0.01% 2493
2015
Q3
$27K Buy
3,085
+6
+0.2% +$53 ﹤0.01% 5202
2015
Q2
$31K Buy
3,079
+333
+12% +$3.35K ﹤0.01% 5141
2015
Q1
$37K Sell
2,746
-4,192
-60% -$56.5K ﹤0.01% 4886
2014
Q4
$89K Buy
+6,938
New +$89K ﹤0.01% 4305